There were 2,008 press releases posted in the last 24 hours and 397,848 in the last 365 days.

Endoscopy Devices Market Size, Share, Demand and Forecast 2024-2032

The global endoscopy devices market size reached US$ 47.1 Billion in 2023.

BROOKLYN, NEW YORK, UNITED STATES, June 16, 2024 /EINPresswire.com/ -- IMARC Group has recently released a new research study titled โ€œEndoscopy Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032โ€, offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends, and competitive landscape to understand the current and future market scenarios.

The global endoscopy devices market size reached US$ 47.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 82.2 Billion by 2032, exhibiting a growth rate (CAGR) of 6.2% during 2024-2032.

๐—š๐—น๐—ผ๐—ฏ๐—ฎ๐—น ๐—˜๐—ป๐—ฑ๐—ผ๐˜€๐—ฐ๐—ผ๐—ฝ๐˜† ๐——๐—ฒ๐˜ƒ๐—ถ๐—ฐ๐—ฒ๐˜€ ๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜ ๐—ง๐—ฟ๐—ฒ๐—ป๐—ฑ๐˜€:

The global endoscopy devices market is being propelled by several key drivers, such as the increasing prevalence of gastrointestinal diseases and disorders such as colorectal cancer, gastroesophageal reflux disease (GERD), and inflammatory bowel disease (IBD) is fostering the demand for endoscopy procedures worldwide. In line with this, technological advancements in endoscopic imaging modalities, such as high-definition (HD) and ultra-high-definition (UHD) systems, are enhancing the visualization and diagnosis capabilities, thereby driving the market growth. Additionally, the rising preference for minimally invasive surgeries (MIS) due to their reduced recovery times, lower risk of complications, and shorter hospital stays is fueling the adoption of endoscopic procedures.

๐—ฅ๐—ฒ๐—พ๐˜‚๐—ฒ๐˜€๐˜ ๐˜๐—ผ ๐—š๐—ฒ๐˜ ๐˜๐—ต๐—ฒ ๐—ฆ๐—ฎ๐—บ๐—ฝ๐—น๐—ฒ ๐—ฅ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜: https://www.imarcgroup.com/endoscopy-devices-market/requestsample

๐—™๐—ฎ๐—ฐ๐˜๐—ผ๐—ฟ๐˜€ ๐—”๐—ณ๐—ณ๐—ฒ๐—ฐ๐˜๐—ถ๐—ป๐—ด ๐˜๐—ต๐—ฒ ๐—š๐—ฟ๐—ผ๐˜„๐˜๐—ต ๐—ผ๐—ณ ๐˜๐—ต๐—ฒ ๐—˜๐—ป๐—ฑ๐—ผ๐˜€๐—ฐ๐—ผ๐—ฝ๐˜† ๐——๐—ฒ๐˜ƒ๐—ถ๐—ฐ๐—ฒ๐˜€ ๐—œ๐—ป๐—ฑ๐˜‚๐˜€๐˜๐—ฟ๐˜†:

๐—ฃ๐—ฟ๐—ฒ๐˜ƒ๐—ฎ๐—น๐—ฒ๐—ป๐—ฐ๐—ฒ ๐—ผ๐—ณ ๐—š๐—ฎ๐˜€๐˜๐—ฟ๐—ผ๐—ถ๐—ป๐˜๐—ฒ๐˜€๐˜๐—ถ๐—ป๐—ฎ๐—น ๐——๐—ถ๐˜€๐—ฒ๐—ฎ๐˜€๐—ฒ๐˜€:

The escalating prevalence of gastrointestinal disorders like colorectal cancer, GERD, and IBD is a significant driver propelling the global endoscopy devices market. As these diseases become more common globally, the demand for endoscopic procedures for diagnosis, surveillance, and treatment has surged. Colorectal cancer, for instance, is one of the most prevalent cancers worldwide, necessitating regular screening via endoscopy for early detection and intervention. Similarly, GERD and IBD affect millions worldwide, requiring frequent monitoring and therapeutic interventions, often performed through endoscopic procedures. Therefore, the increasing burden of gastrointestinal diseases is a crucial factor driving the adoption of endoscopy devices and services.

๐—ง๐—ฒ๐—ฐ๐—ต๐—ป๐—ผ๐—น๐—ผ๐—ด๐—ถ๐—ฐ๐—ฎ๐—น ๐—”๐—ฑ๐˜ƒ๐—ฎ๐—ป๐—ฐ๐—ฒ๐—บ๐—ฒ๐—ป๐˜๐˜€:

Advancements in endoscopic imaging technologies have revolutionized the field of endoscopy by enhancing visualization and diagnostic accuracy. These advancements enable healthcare professionals to detect abnormalities with greater precision and clarity, leading to more accurate diagnoses and improved patient outcomes. High-definition and ultra-high-definition imaging systems offer superior image quality, allowing for better visualization of tissues, lesions, and anatomical structures during endoscopic procedures. Consequently, the adoption of these advanced imaging modalities is rapidly growing, driving the demand for endoscopy devices worldwide.

๐—ฃ๐—ฟ๐—ฒ๐—ณ๐—ฒ๐—ฟ๐—ฒ๐—ป๐—ฐ๐—ฒ ๐—ณ๐—ผ๐—ฟ ๐— ๐—ถ๐—ป๐—ถ๐—บ๐—ฎ๐—น๐—น๐˜† ๐—œ๐—ป๐˜ƒ๐—ฎ๐˜€๐—ถ๐˜ƒ๐—ฒ ๐—ฆ๐˜‚๐—ฟ๐—ด๐—ฒ๐—ฟ๐—ถ๐—ฒ๐˜€:

The increasing preference for minimally invasive surgeries over traditional open procedures is a key driver fueling the growth of the global endoscopy devices market. Minimally invasive techniques, including endoscopic procedures, offer numerous benefits such as shorter hospital stays, reduced postoperative pain, quicker recovery times, and lower risk of complications compared to open surgeries. Patients are increasingly opting for these minimally invasive approaches due to their favorable outcomes and improved quality of life. Endoscopy, as a minimally invasive procedure, allows for the diagnosis and treatment of various conditions without the need for large surgical incisions, making it a preferred choice for both patients and healthcare providers alike.

๐—ž๐—ฒ๐˜† ๐—–๐—ผ๐—บ๐—ฝ๐—ฎ๐—ป๐—ถ๐—ฒ๐˜€:

โ€ข Boston Scientific Corporation
โ€ข Johnson & Johnson
โ€ข FUJIFILM Holdings Corporation
โ€ข HOYA Corporation
โ€ข Karl Storz SE & Co. KG
โ€ข Machida Endoscope Co. Ltd
โ€ข Medtronic Plc
โ€ข Olympus Corporation
โ€ข Richard Wolf GmbH
โ€ข Smith & Nephew plc and Stryker Corporation

๐—˜๐—ป๐—ฑ๐—ผ๐˜€๐—ฐ๐—ผ๐—ฝ๐˜† ๐——๐—ฒ๐˜ƒ๐—ถ๐—ฐ๐—ฒ๐˜€ ๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜ ๐—ฅ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜ ๐—ฆ๐—ฒ๐—ด๐—บ๐—ฒ๐—ป๐˜๐—ฎ๐˜๐—ถ๐—ผ๐—ป:

๐—•๐˜† ๐—ง๐˜†๐—ฝ๐—ฒ:

โ€ข Endoscopes
โ€ข Endoscopy Visualization Systems
โ€ข Endoscopy Visualization Components
โ€ข Operative Devices

Endoscopy visualization systems represented the largest segment due to the increasing demand for advanced imaging modalities enhancing diagnostic accuracy and visualization during endoscopic procedures.

๐—•๐˜† ๐—”๐—ฝ๐—ฝ๐—น๐—ถ๐—ฐ๐—ฎ๐˜๐—ถ๐—ผ๐—ป:

โ€ข Gastrointestinal Endoscopy
โ€ข Urology Endoscopy
โ€ข Laparoscopy
โ€ข Gynecology Endoscopy
โ€ข Arthroscopy
โ€ข Others

Gastrointestinal endoscopy represented the largest segment owing to the rising prevalence of gastrointestinal diseases globally, necessitating frequent endoscopic interventions for diagnosis and treatment.

๐—•๐˜† ๐—˜๐—ป๐—ฑ ๐—จ๐˜€๐—ฒ:

โ€ข Hospitals and Clinics
โ€ข Ambulatory Surgical Centers
โ€ข Others

Hospitals & clinics represented the largest segment because they serve as primary healthcare facilities where the majority of endoscopic procedures are performed, catering to a wide range of patients requiring diagnostic and therapeutic interventions.

๐—ฅ๐—ฒ๐—ด๐—ถ๐—ผ๐—ป๐—ฎ๐—น ๐—œ๐—ป๐˜€๐—ถ๐—ด๐—ต๐˜๐˜€:

โ€ข North America
โ€ข Asia-Pacific
โ€ข Europe
โ€ข Latin America

North America was the largest market due to factors such as well-established healthcare infrastructure, high adoption rates of advanced medical technologies, and increasing prevalence of chronic diseases necessitating endoscopic interventions in the region.

๐—ฆ๐—ฝ๐—ฒ๐—ฎ๐—ธ ๐˜๐—ผ ๐—”๐—ป ๐—”๐—ป๐—ฎ๐—น๐˜†๐˜€๐˜: https://www.imarcgroup.com/request?type=report&id=3835&flag=C

๐—ž๐—ฒ๐˜† ๐—›๐—ถ๐—ด๐—ต๐—น๐—ถ๐—ด๐—ต๐˜๐˜€ ๐—ผ๐—ณ ๐˜๐—ต๐—ฒ ๐—ฅ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜:

โ€ข Market Performance (2018-2023)
โ€ข Market Outlook (2024-2032)
โ€ข Market Trends
โ€ข Market Drivers and Success Factors
โ€ข Impact of COVID-19
โ€ข Value Chain Analysis
โ€ข Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

๐—”๐—ฏ๐—ผ๐˜‚๐˜ ๐—จ๐˜€

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARCโ€™s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companyโ€™s expertise.

Elena Anderson
IMARC Services Private Limited
+1 631-791-1145
email us here